The global neuroscience antibodies and assays market size is expected to reach USD 7.06 Billion by 2028 at a CAGR of 10.4%, according to the latest report by Reports and Data. Increasing prevalence of neurological disorders, rapid advancements in neurological research, and growing support by government and healthcare organizations to accelerate drug discovery and development for neurological disorders are key factors expected to drive market revenue growth over the forecast period. Increasing research and development in biopharmaceutical sector and rising demand for high-quality neuroscience antibodies to study novel and potential drug targets are also expected to drive market growth going ahead.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4060 

Neuroscience is a multidisciplinary field of science focused on studying the structure and function of nervous system. It comprises an integrated analysis of multiple cell types, tissues, and organs using different techniques. Recent advancements in neuroscience research has resulted in increased reliance on antibodies and immunodetection to understand the pathways and targets of neurological diseases. Antibodies, peptides, and proteins have expanded the scope of different areas of neuroscience research. Antibody-based approaches are critical tools in cellular and molecular neuroscience and has increased the knowledge about the abundance, distribution, function, and structure of proteins in the brain. Antibody-based methods are widely used in localization, isolation, and characterization of target proteins that form a fundamental base of neuroscience research. Antibodies targeting specific neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other neurological diseases are widely available, and this is expected to further boost neuroscience research activities and contribute to market growth going ahead.

Rising global prevalence of multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, stroke, and epilepsy among others due to increasing geriatric population is expected to further boost revenue growth of the market over the forecast period. Rapid discovery of novel potential drug targets, signaling molecules, and structural proteins in the brain is also expected to increase demand for neuroscience antibodies and drive market growth. However, stringent regulatory processes and increasing adverse responses to antibodies are expected to restrain market growth to a certain extent over the forecast period.

Some Key Highlights From the Report:

  • Consumables segment is expected to account for largest revenue share in the global market over the forecast period owing to increasing demand and use of reagents, assay kits, and antibodies in neuroscience research activities, rapid progress of proteomics and genomics research, and frequent purchase of consumables.
  • Immunoassays segment is expected to register robust revenue CAGR over the forecast period owing to rapid development of antibodies and assay kits for immunoassays and increasing funding to accelerate research and development activities.
  • In vitro diagnostic application segment is expected to register considerable revenue growth, attributable to rising global healthcare burden of neurological disorders and increasing demand for more efficient diagnosis of conditions and monitoring of therapeutic regimens in patients.
  • Pharmaceutical and biotechnology companies accounted for largest revenue share in 2020 and is expected to register a significantly steady revenue growth rate over the forecast period, attributable to increasing research and development activities, rising demand for neuroscience antibodies in drug research, and advancements in proteomics and genomics research.
  • North America is expected to account for largest revenue share between 2021 and 2028, attributable to increasing incidence of neurological conditions, rising investment to accelerate development of structure-based drug design, and presence of key players in the region.
  • In September 2020, Siemens Healthineers and Novartis Pharma AG signed a collaboration agreement for designing, development, and marketing of diagnostic tests for Novartis’ pipeline therapeutic products. The initial program, under the partnership, will focus on development of serum Neurofilament Light Chain (NfL) immunoassay for patients suffering from multiple sclerosis and other nerve disorders.

Top players profiled in the report include:

Thermo Fisher Scientific, Inc., Abcam, Bio-Rad, Merck KGaA, BioLegend, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, Rockland Immunochemicals, Santa Cruz Biotechnology, Siemens, and Tecan.

Product Outlook (Revenue, USD Billion; 2018-2028)

  • Consumables
    • Reagents
    • Antibodies
      • Primary Antibodies
      • Secondary Antibodies
    • Assay Kits
  • Instruments
    • Microplate Readers
    • Immunoassay Analyzers
    • Other Instruments

Technology Outlook (Revenue, USD Billion; 2018-2028)

  • Immunochemistry/Immunoassays
    • ELISA
    • Western Blotting
    • Others Immunoassays Technologies
  • Molecular Diagnostics
  • Clinical Chemistry
  • Other Technologies

To know more about the report @ https://www.reportsanddata.com/report-detail/neuroscience-antibodies-and-assays-market 

Geographic Segment Covered in the Report:

The Neuroscience Antibodies and Assays report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Summary of the Neuroscience Antibodies and Assays Market Research Report:

  • Insightful information regarding the global Neuroscience Antibodies and Assays market
  • Strategic recommendations for the investment opportunities
  • The report covers significant statistics related to the industry along with products, applications, price analysis, demand & supply, and production and consumptions rate
  • Emerging trends and current market segment analysis to help investors formulate new business strategies
  • Thorough SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4060 

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Read More Reports:

Oleochemicals Market @ https://www.reportsanddata.com/report-detail/oleochemicals-market

Styrene Butadiene Rubber (SBR) Market @ https://www.reportsanddata.com/report-detail/styrene-butadiene-rubber-sbr-market

Fertility Testing Market @ https://www.reportsanddata.com/report-detail/fertility-testing-market

Embolic Protection Devices Market @ https://www.reportsanddata.com/report-detail/embolic-protection-devices-market

Pigmentation Disorders Market @ https://www.reportsanddata.com/report-detail/pigmentation-disorders-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.